Brief: Sarepta Therapeutics Says Douglas Ingram To Retire As CEO Of Sarepta
25/02/2026 23:17
Feb 25 (Reuters) - Sarepta Therapeutics Inc SRPT.O: SAREPTA THERAPEUTICS INC - DOUGLAS INGRAM TO RETIRE AS CEO OF SAREPTA - SEC FILING Further company coverage: SRPT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sarepta Therapeutics
See all newsUS RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Dyne, Sarepta shares tumble as Novartis setback weighs on muscle disease drug developers
U.S. STOCKS ON THE MOVE-Qualcomm, Eaton, Howmet Aerospace
Sarepta, Dyne fall after Novartis muscle disorder trial failure